22
Institutions holding · +15.8% QoQ
Senti Biosciences Holdings I (SNTI) was held by 22 institutions as of Q3 2026, with a combined reported value of $387,402 (−82.4% from the previous quarter). The largest holder was Vanguard Capital Management Llc, reporting $167,701 — 43.3% of the total. The ten largest holders together account for 96.1% of the reported value.
| # | Manager | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 537,504 | +0.0% | $167,701 | 0.0% |
| 2 | Geode Capital Management, Llc | 176,602 | −5.6% | $55,136 | 0.0% |
| 3 | Two Sigma Securities, Llc | 153,480 | — | $47,916 | 0.0% |
| 4 | Gts Securities Llc | 110,000 | — | $34,320 | 0.0% |
| 5 | Vanguard Fiduciary Trust Co | 91,193 | +0.0% | $28,452 | 0.0% |
| 6 | Menlo Ventures Management, L.P. | 35,737 | +0.0% | $11,157 | 0.0% |
| 7 | Northern Trust Corp | 32,154 | +0.0% | $10,038 | 0.0% |
| 8 | Susquehanna International Group, Llp | 23,147 | — | $7,226 | 0.0% |
| 9 | UBS Group AG | 17,402 | +20.6% | $5,430 | 0.0% |
| 10 | Citadel Advisors Llc | 16,365 | −84.7% | $5,109 | 0.0% |
| 11 | XTX Topco Ltd | 14,885 | −37.0% | $4,647 | 0.0% |
| 12 | State Street Corp | 10,010 | +0.0% | $3,125 | 0.0% |
| 13 | Nuveen, LLC | 9,819 | — | $3,019 | 0.0% |
| 14 | Tower Research Capital LLC (TRC) | 8,959 | +22.0% | $2,797 | 0.0% |
| 15 | Royal Bank Of Canada | 4,015 | +0.0% | $1,000 | 0.0% |
| 16 | SBI Securities Co., Ltd. | 523 | +56.6% | $163 | 0.0% |
| 17 | BlackRock, Inc. | 262 | −93.5% | $82 | 0.0% |
| 18 | Morgan Stanley | 160 | −5.3% | $50 | 0.0% |
| 19 | Hrt Financial Lp | 53,827 | — | $16 | 0.0% |
| 20 | Virtu Financial LLC | 47,271 | +107.4% | $15 | 0.0% |
| 21 | Barclays Plc | 10 | −98.7% | $3 | 0.0% |
| 22 | Caitong International Asset Management Co., Ltd | 1 | +0.0% | $0 | 0.0% |
| Filer | Form | Shares owned | % of class | Event date | Filed | Filing |
|---|---|---|---|---|---|---|
| New Enterprise Associates 15, L.P. | SC 13D/A | 442,615 | 9.6% | 2024-12-02 | 2024-12-04 | EDGAR ↗ |
| Nantahala Capital Management, LLC | SC 13G/A | 2,220,000 | 8.1% | 2025-03-31 | 2025-05-15 | EDGAR ↗ |
| Armistice Capital, Llc | SC 13G/A | 1,439,812 | 5.0% | 2025-03-31 | 2025-05-15 | EDGAR ↗ |
| Nantahala Capital Partners Limited Partnership | SC 13G/A | 502,500 | 1.9% | 2025-03-31 | 2025-05-15 | EDGAR ↗ |
| Insider | Role | Date | Transaction | Shares | Price | Shares after | Filing |
|---|---|---|---|---|---|---|---|
| Celadon Partners SPV 24 | 10% owner | 2025-03-10 | C · Conversion | +9,777,000 | — | 9,777,000 | EDGAR ↗ |
| New Enterprise Associates 15, L.P. | Other | 2025-03-10 | C · Conversion | +3,333,000 | — | 3,775,615 | EDGAR ↗ |
| Bayer Healthcare Llc | 10% owner | 2025-03-10 | C · Conversion | +2,222,000 | — | 2,809,848 | EDGAR ↗ |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | 2025-03-10 | C · Conversion | +33,000 | $2.25 | 33,000 | EDGAR ↗ |
| Lu Timothy K | CEO and Interim PFO and PAO | 2025-03-07 | A · Grant / award | +642,358 | $0.00 | 724,440 | EDGAR ↗ |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | 2025-03-07 | A · Grant / award | +78,363 | $0.00 | 86,984 | EDGAR ↗ |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | 2025-02-06 | S · Open-market sale | −182 | $4.37 | 8,621 | EDGAR ↗ |
| Lu Timothy K | CEO | 2025-02-06 | S · Open-market sale | −545 | $4.36 | 82,082 | EDGAR ↗ |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | 2025-02-04 | S · Open-market sale | −1,297 | $4.07 | 8,803 | EDGAR ↗ |
| Lu Timothy K | CEO | 2025-02-04 | S · Open-market sale | −3,922 | $4.07 | 82,627 | EDGAR ↗ |